Yale School of Medicine

28 results

Rate Search Results

News
Yale Pathologists Share Insight, Latest Research at USCAP 2025
Faculty, Residents, and Clinical Fellows from Yale Pathology had a strong presence at USCAP 2025, the 114th annual meeting of the United States and Canadian Academy of Pathology, held March 22 to 27 in Boston.
27 Mar 2025
News
Yale Ob/Gyn Faculty Present the Latest in Gynecologic Oncology at Memorial Conference
Yale Ob/Gyn faculty presented their research during the Yale Cancer Center and Smilow Cancer Hospital's 39th Annual Ella T. Grasso Memorial Conference in Gynecologic Oncology, held on Nov. 6 at the Yale West Haven Campus.
7 Nov 2024
News
Pei Hui, MD, PhD, Chosen as President-Elect of International Society of Gynecological Pathologists
Pei Hui, MD, PhD, Professor of Pathology and of Obstetrics, Gynecology & Reproductive Sciences at Yale School of Medicine, has been chosen as President-Elect of the International Society of Gynecologic Pathologists.
1 Jul 2024
News
Genetic Analysis of Rare, Often Deadly Cervical Cancer Uncovers Potential Treatments
Yale Cancer Center researchers at Yale School of Medicine analyze the genetic landscape of 66 tumors, the largest series of cervical neuroendocrine tumors ever reported in scientific literature.
15 Apr 2024
News
Topical Shows Promise in Treating Precancerous Cervical Condition
A phase II trial of a topical treatment, led by Yale Cancer Center researchers, shows its promise as a non-invasive treatment for individuals with cervical intraepithelial neoplasia.
9 Apr 2024
News
Yale Diagnostic Pathology Annual CME Review held in NYC
The second Yale Diagnostic Pathology Annual CME Review was held November 4 and 5 at the Yale Club of New York City.
7 Nov 2023
News
Pei Hui, MD, Discusses New Reporting Guidelines for Gestational Trophoblastic Disease
Pei Hui, MD, PhD, Professor of Pathology and of Obstetrics, Gynecology and Reproductive Sciences, discusses updated reporting guidelines for Gestational Trophoblastic Disease.
Source: International Society of Gynecologic Pathologists
25 May 2023
News
Gynecologic Cancer Awareness Q&A with Pei Hui, PhD, MD
Q&A with Pei Hui, PhD, MD, a surgical pathologist, in recognition of Gynecologic Cancer Awareness Month.
13 Sep 2022
News
Yale Pathology Diagnostic Pathology CME Annual Review Scheduled for September 17-18 at Yale Club of NYC
The Yale Department of Pathology presents its inaugural Diagnostic Pathology CME Annual Review on September 17-18 at the Yale Club of New York City. This inaugural course at the Yale Club in the heart of Midtown Manhattan will focus on the recent World Health Organization updates in all major pathology subspecialties.
2 May 2022
News
Yale Pathologists Participating in Annual USCAP Meeting to Share Research, Advancements
Pathologists and research scientists from Department of Pathology at Yale School of Medicine will be involved in more than 40 presentations and sessions at the United States and Canadian Academy of Pathology (USCAP) 2022 Annual Meeting in Los Angeles March 19-24.
18 Mar 2022
News
Yale Gynecologic Pathologists Are Pioneers in Clinical Validation and Application of Molecular Genotyping for Gestational Trophoblastic Disease
Yale Pathology’s experienced gynecological pathologists are pioneers in the clinical validation and application of molecular genotyping for gestational trophoblastic disease (GTD).
6 Feb 2022
News
Pathologist Pei Hui, MD, PhD, on Cervical Health Awareness Month
Pathologist Pei Hui, MD, PhD, discusses preventative measures to protect cervical health, how his team at Gynecologic Pathology collaborates with the gynecologic oncology team at Smilow Cancer Hospital to care for patients, and
11 Jan 2022
News
The Role of Genotyping in the Diagnosis and Prognostication of Gestational Trophoblastic Disease
In this episode of MODPATH CHAT, our guests Dr. Natalia Buza and Dr. Pei Hui from the department of Pathology at Yale University share their approach to the application of DNA genotyping to the diagnosis and prognostication of Hydatidiform moles and Gestational trophoblastic tumors. Genotyping is now the gold standard in the confirmation and subtyping of sporadic hydatidiform moles. DNA genotyping is critical to the separation of gestational trophoblastic neoplasia from non-gestational counterparts/mimics of either germ cell or somatic origin.
Source: ModPathChat
29 Sep 2021
News
Yale Researchers Find First Cases of New UK Coronavirus Variant in Connecticut
The variant cases were rapidly identified through a strong collaborative network at Yale to increase surveillance for the B.1.1.7 variant. The nasal swabs were tested by the Yale Pathology Lab and sequenced by the Yale School of Public Health.
Source: YaleNews
8 Jan 2021
News
Yale researchers find first cases of new UK coronavirus variant in Connecticut
Gov. Ned Lamont on Jan. 7 announced that Yale researchers in collaboration with the Connecticut Department of Public Health (DPH) detected the first two cases of the SARS-CoV-2 variant B.1.1.7 in the state. This is the same variant initially discovered in the United Kingdom that is associated with increased transmission.
Source: Yale News
7 Jan 2021
News
Collaboration Between Public Health and Pathology Is Testament to the Power of Teamwork in a Pandemic
The Yale-developed SalivaDirect test for COVID-19 came into reality with a large boost from Yale School of Medicine's Department of Pathology.
11 Sep 2020
News
Quick and affordable saliva-based COVID-19 test developed by Yale scientists receives FDA Emergency Use Authorization
A saliva-based laboratory diagnostic test developed by researchers at the Yale School of Public Health to determine whether someone is infected with the novel coronavirus has been granted an emergency use authorization by the U.S. Food and Drug Administration (FDA).
Source: Yale News
15 Aug 2020
News
Yale Cancer Center Study Validates Combination Therapy for Aggressive Endometrial Cancer
Yale Cancer Center (YCC) scientists have found that combining the targeted drug trastuzumab with chemotherapy significantly improves survival rates for women with a rare, aggressive form of endometrial cancer. These results may help to change the standard of care worldwide for the disease. The findings are published today in the journal Clinical Cancer Research.
29 Jun 2020
News
Yale Cancer Center Study Validates Combination Therapy for Aggressive Endometrial Cancer
Yale Cancer Center (YCC) scientists have found that combination therapy significantly improves survival rates for women with a rare, aggressive form of endometrial cancer
29 Jun 2020
News
Over 200 Yale Medicine Physicians Make 2019 ‘Best Doctors’ List
Connecticut Magazine’s 2019 “Best Doctors” list includes 217 Yale Medicine physicians in 50 specialties who were selected by their peers as the best in their fields.
14 Jun 2019